Mayank
Analyst
B-Reilly
Equibles does not estimate personal net worth.
About Mayank
Mayank is recorded as Analyst at B-Reilly. Mayank has spoken on 1 earnings call across 1 company, most recently for Kymera Therapeutics, Inc. on February 26, 2026. The companies whose calls Mayank spoke on are classified in the Healthcare sector.
Mayank on recent calls
“On asthma trial, if you could kindly confirm the dose levels are the same as broadened 2, and how might you be enriching for phenol in your target patient population?”
Affiliation history
-
B-Reilly
Analyst
Transcript header (unverified)
Current